41 – 50 of 132
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Discordant amyloid-β PET and CSF biomarkers and its clinical consequences
(
- Contribution to journal › Article
-
Mark
α-synuclein−lipoprotein interactions and elevated ApoE level in cerebrospinal fluid from Parkinson’s disease patients
2019) In Proceedings of the National Academy of Sciences of the United States of America 116(30). p.15226-15235(
- Contribution to journal › Article
-
Mark
Method comparison study of the Elecsys® β-Amyloid (1–42) CSF assay versus comparator assays and LC-MS/MS
(
- Contribution to journal › Article
-
Mark
Assessment of Brain Injury and Brain Volumes after Posthemorrhagic Ventricular Dilatation : A Nested Substudy of the Randomized Controlled ELVIS Trial
(
- Contribution to journal › Article
- 2018
-
Mark
Aquaporin-4-dependent glymphatic solute transport in the rodent brain
(
- Contribution to journal › Article
-
Mark
Amyloid network topology characterizes the progression of Alzheimer's disease during the predementia stages
(
- Contribution to journal › Article
-
Mark
Investigation of cerebrospinal fluid flow in the cerebral aqueduct using high-resolution phase contrast measurements at 7T MRI
(
- Contribution to journal › Article
-
Mark
A critical evaluation of wet biomarkers for huntington's disease : Current status and ways forward
(
- Contribution to journal › Scientific review
-
Mark
The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis : A review
(
- Contribution to journal › Scientific review
-
Mark
Update on biomarkers for amyloid pathology in Alzheimer's disease
(
- Contribution to journal › Scientific review